This week, Impellia, a sports medicine tech company founded by Charlie Batch, was featured in USA Today. The article highlights the ways in which “a flood of information” is being analyzed by the NFL.
The story notes that, during the NFL combine, Batch and his partners presented their product (which is used by teams at the University of Michigan) to the training staffs of all 32 teams and conducted follow-up meetings with eight of them.
“Everybody’s looking to do something with it,” Batch said. “It was like, ‘If you can do that, yes, that’s something we’re interested in.’ ”
Find the full story on USA Today’s website.
